PCM Control Strategy Material Characterization (On-Demand)

Curriculum

Course Description:

Process development of a Pharmaceutical Continuous Manufacturing (PCM) oral solid dose (OSD) drug product serves to identify all sources of variation and their impact on the quality of the final product. Implementing measures to properly mitigate or compensate for variations ensures that a product that goes to the patient meets pre-established quality specifications. This set of measures is called a control strategy: it takes into consideration the dynamic nature of a continuous process.
Measurement tools and models give a deeper understanding of process behaviors, like viewing your process in a higher resolution. During this webinar you will learn why better control over quality is one of the many advantages PCM technology offers.
Sources of Variation
Raw materials may not be perfectly homogeneous: variations in characteristics like density, particle size distribution, and humidity, can impact the quality of the final product. In a batch process, ingredients are blended in a bin blender to assure homogeneity and minimal impact of ingredient variations. In a continuous process, this needs to be done in-line, and in a dynamic environment. In this webinar we will explain how homogeneity can be achieved in time.
Control Strategies
We will show what tools and measures to put in place to assure that a continuous line consistently produces high quality material, and properly separates material that is not within specifications. Having tools and sensors that generate valuable process data enables Real Time Release, and significantly reduces time between start of production and product delivery to patients.

Who should participate:

Drug manufacturing, pharmaceutical manufacturing, biologics organizations; Job function: quality assurance (QA), quality control (QC), operations managers, quality management, pharmaceutical quality directors, managers, scientists, OSD, direct product, quality

Though this course is being made available on USP’s
Education site, the course content was developed by Pharmatech Associates, a
USP company.  USP has not independently reviewed or verified the accuracy
of the course content.

Access Duration:
Access to this course expires 60 days from the date of registration or until you mark the course ‘Complete’ – whichever occurs first.

Speaker:

Richard